Author | Betty Hamilton, MD | OncLive

Author | Betty Hamilton, MD


Dr. Hamilton on Prognostic Impact of Molecular Mutations in AML and MDS on HCT Outcomes

January 29, 2016


Betty Hamilton, MD, associate staff physician, Department of Hematologic Oncology and Blood Disorders and Blood and Marrow Transplant Program, discusses the prognostic impact of molecular mutations in acute myeloid leukemia and myelodysplastic syndromes on allogeneic hematopoietic cell transplant outcomes and the adverse impact of TET2 mutations.